Blue Cross Blue Shield - Mass NPWT Coverage

Medical Necessity and Coverage Criteria

Initiation (Initial Therapy)

Covered when ALL of the following are met:

Overall initiation

1. Prior conservative measures: Adequate wound healing is not occurring despite appropriate application of dressings to maintain a moist environment; debridement of necrotic tissue if present; evaluation of and provision for adequate nutritional status; and appropriate management of underlying medical conditions (eg, diabetes, venous insufficiency)
2. Eligible conditions (one or more): Individual must meet one or more of the listed eligible conditions
Includes: stage III or IV pressure ulcers (with appropriate turning/positioning; support surface if on posterior trunk/pelvis; moisture/incontinence management); diabetic neuropathic ulcers (on a comprehensive diabetic management program and with pressure reduction/offloading); ulcers related to venous or arterial insufficiency (consistent compression and pressure reduction; for home initiation, ulcer present >= 30 days); dehisced wounds or wounds with exposed hardware or bone; post-sternotomy wound infection or mediastinitis; complications of surgically created wounds needing accelerated granulation when other topical treatments are insufficient; skin graft support when graft success is questionable (coverage limited to 5 days); wounds with massive exudate/transudate
3. Absence of absolute contraindications: Wound to be treated is free from exposed anastomotic site, exposed nerves, exposed organs, exposed vasculature, malignancy in the wound, necrotic tissue with eschar present, non-enteric unexplored fistulas, untreated osteomyelitis, or macroscopic contamination
4. Adjunct or alternative to surgery: The powered NPWT system is being used as an adjunct therapy or as an alternative to surgery
5. Patient compliance: Medical record documents patient willing and able to comply with using continuous or intermittent V.A.C. application 22 of 24 hours per day22 of 24 hours per day

Administrative prerequisite: Documentation by a licensed medical professional of wound evaluation and care (including wound measurements) is present in the medical record

Required prior to use

Continuation Therapy

Continued use is covered when ALL of the following are met:

Continued use criteria: Weekly assessment by a licensed health care professional; the initial trial resulted in documented objective improvements in the wound; and documentation of continued progressive wound healingWeekly

If these are not met, continued use is considered not medically necessary

Evidence-based stance by indication

Policy's evidence-based coverage conclusions by clinical indication:

Diabetic lower-extremity ulcers or amputation wounds: Outpatient NPWT: systematic reviews and RCTs show higher wound healing rates and fewer amputations with NPWT though trials had risk of bias; overall evidence considered sufficient to demonstrate improvement in net health outcome. Portable, single‑use devices (eg, PICO, SNaP): RCTs show noninferiority for wound area reduction but evidence is insufficient for consistent benefit in complete wound closure; overall insufficient to conclude improvement in net health outcome for single‑use devices.

Device-specific conclusions vary; larger well-designed trials needed for single‑use devices

Chronic pressure ulcers: RCTs and systematic reviews are low quality and at high risk of bias, most data from inpatient settings; evidence is insufficient to determine improvement in net health outcome for outpatient NPWT.

Lower-extremity venous ulcers: Limited RCT evidence; inpatient studies of NPWT as adjunct to skin grafts show faster healing but no outpatient primary treatment studies; RCTs of single‑use devices show noninferiority for wound area but no consistent benefit for complete closure; evidence insufficient for outpatient NPWT to improve net health outcome.

Electrically powered negative pressure wound therapy (NPWT) is considered INVESTIGATIONAL for any application that does not meet the medical necessity criteria listed in this policy. This includes situations where the wound does not satisfy the initiation or continuation requirements, or when any of the policy’s absolute contraindications are present (for example: exposed anastomotic site, exposed nerves, exposed organs or vasculature, malignancy in the wound, necrotic tissue with eschar, non-enteric unexplored fistulas, untreated osteomyelitis, or macroscopic contamination).

Non‑electrically powered negative pressure wound therapy devices (for example, the SNaP™ system) are considered INVESTIGATIONAL for all indications and are not covered under this policy.

Portable, battery‑powered, single‑use (disposable) NPWT systems (for example, PICO™ or V.A.C.Via™) are considered INVESTIGATIONAL for all conditions. Although some randomized trials have evaluated single‑use devices in outpatient populations, the evidence is insufficient to conclude these devices improve net health outcomes across indications; therefore coverage is not supported by this policy.

The use of CPT codes 97607 and 97608 and HCPCS code A9272 is designated as INVESTIGATIONAL for Commercial Members (Managed Care, PPO, Indemnity). Claims submitted with these codes for covered populations may be subject to denial per the investigational coding stance.

Continued use of electrically powered NPWT is considered NOT MEDICALLY NECESSARY when the policy’s continuation criteria are not met. Continuation requires documented weekly wound assessment by a licensed health care professional, objective improvement documented during the initial trial, and evidence of continued progressive wound healing; absence of these elements will render ongoing therapy not medically necessary.

The policy summarizes evidence by indication and finds varying strength of data: for outpatient diabetic lower‑extremity or amputation wounds, RCTs and systematic reviews show higher healing rates and fewer amputations with NPWT (evidence judged sufficient for general electrically powered NPWT), whereas for chronic pressure ulcers, venous leg ulcers, burn wounds, and many traumatic or surgical wound scenarios the evidence is insufficient to determine an improvement in net health outcome for outpatient or portable single‑use NPWT. Single‑use/portable devices have shown noninferiority for wound area reduction in some trials but lack robust data on complete wound closure and long‑term outcomes.

Billing and Diagnosis Codes

Covered CPT CodesCPTCovered

97605	Negative pressure wound therapy, including topical application(s), wound assessment, and instruction(s) for ongoing care, per session; total wound(s) surface area less than or equal to 50 square centimeters.
97606	Negative pressure wound therapy, including topical application(s), wound assessment, and instruction(s) for ongoing care, per session; total wound(s) surface area greater than 50 square centimeters.

Covered HCPCS CodesHCPCSCovered

A6550	Wound care set, for negative pressure wound therapy electrical pump, includes all supplies and accessories.
E2402	Negative pressure wound therapy electrical pump, stationary or portable.

Relevant ICD-10 Diagnosis Codes (selected excerpt)ICD-10

E08.621	Diabetes mellitus due to underlying condition with foot ulcer.
E09.621	Drug or chemical induced diabetes mellitus with foot ulcer.
E10.621	Type 1 diabetes mellitus with foot ulcer.
E11.621	Type 2 diabetes mellitus with foot ulcer.
E13.621	Other specified diabetes mellitus with foot ulcer.
I70.231	Atherosclerosis of native arteries of right leg with ulceration of thigh.
I70.232	Atherosclerosis of native arteries of right leg with ulceration of calf.
I70.233	Atherosclerosis of native arteries of right leg with ulceration of ankle.
I70.234	Atherosclerosis of native arteries of right leg with ulceration of heel and midfoot.
I70.235	Atherosclerosis of native arteries of right leg with ulceration of other part of foot.

1–10 of 15

1/2

Investigational CPT CodesCPTNot Covered

97607	Negative pressure wound therapy, per session; total wound surface area <= 50 sq cm
97608	Negative pressure wound therapy, per session; total wound surface area > 50 sq cm

Investigational HCPCS CodesHCPCSNot Covered

A9272

Mechanical wound suction, disposable, includes dressing and all accessories and components, each

ICD-10 Diagnosis Codes (partial list from document)ICD-10

T81.30XA	Disruption of wound, unspecified, initial encounter
T81.30XD	Disruption of wound, unspecified, subsequent encounter
T81.30XS	Disruption of wound, unspecified, sequela
T81.31XA	Disruption of external operation (surgical) wound, initial encounter
T81.31XD	Disruption of external operation (surgical) wound, subsequent encounter
T81.31XS	Disruption of external operation (surgical) wound, sequela
T81.32XA	Disruption of internal operation (surgical) wound, initial encounter
T81.32XD	Disruption of internal operation (surgical) wound, subsequent encounter
T81.32XS	Disruption of internal operation (surgical) wound, sequela
T81.89XA	Other complications of procedures, not elsewhere classified, initial encounter

1–10 of 22

1/3

Wound surface area — <= 50 sq cm (97605) vs > 50 sq cm (97606)

CPT code (<=50 sq cm)97605 — Negative pressure wound therapy; total wound(s) surface area less than or equal to 50 square centimeters.

CPT code (>50 sq cm)97606 — Negative pressure wound therapy; total wound(s) surface area greater than 50 square centimeters.

Usage contextCodes describe NPWT per session including topical application(s), wound assessment, and instruction(s) for ongoing care.

Wound surface area thresholds in CPT — <= 50 sq cm (97607); > 50 sq cm (97608)

CPT code (<=50 sq cm, disposable system)

Prior Authorization, Documentation, and Administrative Guidance

Prior Authorization

Prior Authorization Guidance

Inpatient procedures described in this policy require precertification/preauthorization. For outpatient services, prior authorization is not required for Commercial Managed Care (HMO and POS) and Commercial PPO members. Providers should consult plan-specific resources for any variations in managed care or indemnity/PPO rules.

Inpatient: Precertification/preauthorization IS REQUIRED for all products when performed inpatient.
Outpatient: Commercial Managed Care (HMO and POS) = Prior authorization is not required; Commercial PPO, Outpatient = Prior authorization is not required.
Policy history notes that prior authorization was removed in 11/2024 — verify plan-specific rules for any exceptions.

Denial Risk

Denial Risk for Continued Use Without Documented Improvement

Continued use of electrically powered NPWT must show documented, objective wound improvement. If weekly assessments, initial objective improvement, and ongoing progressive healing are not documented, continuation is considered NOT MEDICALLY NECESSARY and may be denied.

Clinical Background and Scope

Negative pressure wound therapy (NPWT) is a modality that applies subatmospheric pressure to a wound bed to remove exudate, reduce edema, and promote granulation tissue formation. It may be used as an adjunct to standard wound care or, in selected patients who are poor surgical candidates, as an alternative to operative intervention. The policy addresses electrically powered systems for a range of wound types and specifies clinical prerequisites, contraindications, and documentation and monitoring expectations for safe and appropriate use.

Key Terms and Device Types

Eligible conditions

Stage III/IV pressure ulcersStage III or IV pressure ulcers at initiation when individual has appropriate turning/positioning, pelvic/trunk ulcers have group 2 or 3 support surface, and moisture/incontinence are managed.

Diabetic neuropathic foot ulcersDiabetic neuropathic ulcers in individuals on a comprehensive diabetic management program with reduction in pressure (offloading) accomplished.

Other eligible conditionsUlcers from venous/arterial insufficiency (with consistent compression and offloading; home initiation requires ulcer present ≥30 days), dehisced wounds or wounds with exposed hardware or bone, post-sternotomy wound infection/mediastinitis, complications of surgically created wounds needing accelerated granulation, skin graft support when success is questionable (coverage limited to 5 days), and wounds with massive exudate/transudate.

Negative pressure wound therapy (NPWT) — definition of NPWT

DefinitionNegative pressure wound therapy (NPWT) uses a negative pressure or suction device to aspirate and remove fluids, debris, and infectious materials from the wound bed to promote formation of granulation tissue.

OpenPayer

Electrically powered negative pressure wound therapy (NPWT) — coverage criteria

Medical Necessity and Coverage Criteria

Billing and Diagnosis Codes

Prior Authorization, Documentation, and Administrative Guidance

Clinical Background and Scope

Key Terms and Device Types